Reuters/Ipsos Coronavirus Impact on Recreation (04/29/2020)
Washington, DC, April 29, 2020 — A recent Reuters/Ipsos poll finds that some Americans are apprehensive about returning to activities involving large crowds, like professional sports games, live concert and theatre performances, movie theatres, and amusement parks until there is a proven vaccine for the coronavirus.
- About a quarter said they would return to live concerts, theatres and movie theatres as soon as they reopen to the public (27%), but one-third said they would wait until there is a proven vaccine (32%).
- About 1 in 5 said they would visit an amusement park right when they re-opened, but 30% said they would wait until there is a vaccine.
- A quarter of Americans would return to professional sports games when a vaccine is available, but just 17% said they would attend when the leagues begin hosting games with live audiences.
About the Study
These are some of the findings of an Ipsos poll conducted between April 15-21, 2020 on behalf of Thomson Reuters. For this survey, a sample of 4,429 Americans age 18+ from the continental U.S., Alaska and Hawaii were interviewed online in English. Weighting was then employed to balance demographics to ensure that the sample's composition reflects that of the adult population according to Census data and to provide results intended to approximate the sample universe. The precision of Ipsos online polls is measured using a credibility interval. In this case, the poll is accurate to within ± 1.7 percentage points, 19 times out of 20, had all Americans been polled. The credibility interval will be wider among subsets of the population. All sample surveys and polls may be subject to other sources of error, including, but not limited to coverage error, and measurement error.
For more information on this news release, please contact:
Chris Jackson
Vice President, US
Public Affairs
+1 202 420-2025
[email protected]
Kate Silverstein
Media Relations, US
Public Affairs
+1 718 755-8829
[email protected]
About Ipsos
Ipsos is the world’s third largest market research company, present in 90 markets and employing more than 18,000 people.
Our passionately curious research professionals, analysts and scientists have built unique multi-specialist capabilities that provide true understanding and powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. We serve more than 5000 clients across the world with 75 business solutions.
Founded in France in 1975, Ipsos is listed on the Euronext Paris since July 1st, 1999. The company is part of the SBF 120 and the Mid-60 index and is eligible for the Deferred Settlement Service (SRD).
ISIN code FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP
